(Q43007771)

12 November 2017

Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin (English)

1 reference

12 November 2017

0 references

0 references

1 reference

chronic periodontitis

1 reference

Hesham El-Sharkawy

1

1 reference

12 November 2017

Nayer Aboelsaad

2

1 reference

12 November 2017

Mohamed Eliwa

3

1 reference

12 November 2017

Mahmoud Darweesh

4

1 reference

12 November 2017

Mohammad Alshahat

5

1 reference

12 November 2017

Alpdogan Kantarci

6

1 reference

12 November 2017

Hatice Hasturk

7

1 reference

12 November 2017

Thomas E Van Dyke

8

1 reference

12 November 2017

language of work or name

English

0 references

publication date

23 June 2010

1 reference

Journal of Periodontology

12 November 2017

1 reference

12 November 2017

81

1 reference

12 November 2017

11

1 reference

12 November 2017

1635-1643

1 reference

Lipoxin signaling in neutrophils and their role in periodontal disease

12 November 2017

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Development of a risk profile for periodontal disease: microbial and host response factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

The role of inflammatory mediators in the pathogenesis of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

New directions in host modulation for the management of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Host response modulation in the management of periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Novel chemical mediators in the resolution of inflammation: resolvins and protectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Omega-3 fatty acid effect on alveolar bone loss in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Omega-3 fatty acid regulates inflammatory cytokine/mediator messenger RNA expression in Porphyromonas gingivalis-induced experimental periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Intravenous application of omega-3 fatty acids in patients with active rheumatoid arthritis. The ORA-1 trial. An open pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Lipoxins and resolvins in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Inflammation and bone loss in periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Matrix metalloproteinase-8 concentration in shallow crevices associated with the extent of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Endogenous receptor agonists: resolving inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Clinical relevance of adjunctive minocycline microspheres in patients with chronic periodontitis: secondary analysis of a phase 3 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2010.090628

21 January 2018

Identifiers

DOI

10.1902/JOP.2010.090628

1 reference

12 November 2017

1 reference